Important: Read our coronavirus (COVID-19) statement here.
 
 
Contact The Center for Community Practice Today
585-274-3044
RECENT NEWS
PREP DURING COVID-19 LONGTERM INJECTABLE DRUG PREVENTS HIV AMONG MEN WHO HAVE SEX WITH MEN, AND TRANSGENDER WOMEN AFRICAN AMERICAN MEDICAL MISTRUST – TUSKEGEE SYPHILIS STUDY AND MORE COULD THIS AFFECT THE BLACK COMMUNITY’S RESPONSE TO COVID-19? COVID-19 EXACERBATING INEQUALITIES IN THE US INSIDE THE MONROE COUNTY CONTACT TRACING TEAM THAT’S CONTAINING THE SPREAD OF COVID-19 CORONAVIRUS: STRESS AND COPING COVID-19: SPECIAL CONSIDERATIONS FOR PEOPLE LIVING WITH HIV WHAT TO KNOW ABOUT HIV AND COVID-19 IMPORTANT: READ OUR CORONAVIRUS (COVID-19) STATEMENT HERE. IT TAKES MORE THAN PENICILLIN TO END A SYPHILIS EPIDEMIC SHOULD ALL PREP USERS ON TRUVADA SWITCH TO DESCOVY? THESE LEADING DOCS SAY, ‘NOT SO FAST.’ HIV VACCINE IN 2021? LEADING EXPERTS 'OPTIMISTIC' ABOUT ONGOING TRIALS EFFORTS TO END THE HIV EPIDEMIC MUST NOT IGNORE PEOPLE ALREADY LIVING WITH HIV Q&A: INCREASED FUNDING FOR STD PREVENTION A ‘DOWN PAYMENT’ HAPPY NEW YEAR--BUILDING ON THE PAST SUCCESSES THE NUMBERS CONTINUE TO RISE – SUMMARY OF 2018 CDC STD SURVEILLANCE REPORT NIH STUDY TO EXPLORE VACCINE FOR GONORRHEA PREVENTION SYRINGE EXCHANGE SAVED BILLIONS IN HIV-RELATED COSTS IN PHILADELPHIA, STUDY FINDS MISLEADING ADS ABOUT PREP ARE THREATENING PROGRESS TO END THE HIV EPIDEMIC SURVEY: ALCOHOL AND METH USE HAVE BIGGEST IMPACT ON HIV VIRAL SUPPRESSION CALIFORNIA TO MAKE HIV PREVENTION DRUGS AVAILABLE WITHOUT A PRESCRIPTION THREE STDS ARE AT AN ALL-TIME HIGH. AND NOT BECAUSE OF PREP OR MORE RISKY SEX NIH TAPS URMC TO HELP DEVELOP NEW PAIN RELIEVERS TO COMBAT OPIOID CRISIS NEW CDC REPORT: STDS CONTINUE TO RISE IN THE U.S. FDA APPROVES SECOND DRUG TO PREVENT HIV INFECTION AS PART OF ONGOING EFFORTS TO END THE HIV EPIDEMIC PROMOTING HIV TESTING AND PREVENTION: NATIONAL LATINX AIDS AWARENESS DAY EASY PEASY MEASURES PLEASE: EPMP IN HIV PROGRAMS HE EMERGED FROM PRISON A POTENT SYMBOL OF H.I.V. CRIMINALIZATION WHAT IS MINORITY STRESS? HIV TESTING IN 50 LOCAL JURISDICTIONS ACCOUNTING FOR THE MAJORITY OF NEW HIV DIAGNOSES AND SEVEN STATES WITH DISPROPORTIONATE OCCURRENCE OF HIV IN RURAL AREAS, 2016–2017 THESE 10 U.S. CITIES JUST GOT NEARLY $100K EACH TO END HIV NEW STUDY SUPPORTS EXPANDED TESTING FOR GONORRHEA AND CHLAMYDIA SO…YOU WANT TO IMPLEMENT A HIGH-IMPACT PREVENTION (HIP) INTERVENTION? YES, YOU CAN GET THROAT GONORRHEA FOCUSING ON HIV TESTING AND DIAGNOSIS: NATIONAL HIV TESTING DAY 2019 FDA CLEARS FIRST DIAGNOSTIC TESTS FOR EXTRAGENITAL TESTING FOR CHLAMYDIA AND GONORRHEA TRAUMA INFORMED CARE MY HERPES: FROM SHAME TO EMPOWERMENT MEASLES OUTBREAK AND PEOPLE LIVING WITH HIV FDA APPROVES FIRST TWO-DRUG COMPLETE REGIMEN FOR HIV-INFECTED PATIENTS WHO HAVE NEVER RECEIVED ANTIRETROVIRAL TREATMENT STDS--WHAT TO KNOW, WHAT TO DO. PUBLIC HEALTH WORKERS TAKING ACTION ON RISING US STD RATES: GONORRHEA, SYPHILIS MAKING COMEBACKS EXPEDITED PARTNER THERAPY TO TREAT PERSONS EXPOSED TO CHLAMYDIA TEACHING ADULTS IS EASY, RIGHT? IN LOS ANGELES, A NOVEL PLAN TO END CONGENITAL SYPHILIS A DEVASTATING SURGE IN CONGENITAL SYPHILIS: HOW CAN WE STOP IT? CDC DATA CONFIRM: PROGRESS IN HIV PREVENTION HAS STALLED TIPS FOR ANAL HEALTH – WAYS TO TAKE CARE OF YOUR BOTTOM TWO COMMON STDS THREATEN ADVANCES IN HIV FOR HIV, TREATMENT IS PREVENTION NATIONAL BLACK HIV/AIDS AWARENESS DAY
Copyright © University of Rochester Center for Community Practice 2020 - All rights reserved
Web Design by Scriptable Solutions